Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 May 25;269(1):212–224. doi: 10.1006/viro.2000.0219

Coronavirus-Induced Membrane Fusion Requires the Cysteine-Rich Domain in the Spike Protein

Kevin W Chang 1, YiWei Sheng 1, James L Gombold 1,1
PMCID: PMC7131280  PMID: 10725213

Abstract

The spike glycoprotein of mouse hepatitis virus strain A59 mediates the early events leading to infection of cells, including fusion of the viral and cellular membranes. The spike is a type I membrane glycoprotein that possesses a conserved transmembrane anchor and an unusual cysteine-rich (cys) domain that bridges the putative junction of the anchor and the cytoplasmic tail. In this study, we examined the role of these carboxyl-terminal domains in spike-mediated membrane fusion. We show that the cytoplasmic tail is not required for fusion but has the capacity to enhance membrane fusion activity. Chimeric spike protein mutants containing substitutions of the entire transmembrane anchor and cys domain with the herpes simplex virus type 1 glycoprotein D (gD-1) anchor demonstrated that fusion activity requires the presence of the A59 membrane-spanning domain and the portion of the cys domain that lies upstream of the cytoplasmic tail. The cys domain is a required element since its deletion from the wild-type spike protein abrogates fusion activity. However, addition of the cys domain to fusion-defective chimeric proteins was unable to restore fusion activity. Thus, the cys domain is necessary but is not sufficient to complement the gD-1 anchor and allow for membrane fusion. Site-specific mutations of conserved cysteine residues in the cys domain markedly reduce membrane fusion, which further supports the conclusion that this region is crucial for spike function. The results indicate that the carboxyl-terminus of the spike transmembrane anchor contains at least two distinct domains, both of which are necessary for full membrane fusion.

References

REFERENCES

  • 1.Abraham S., Kienzle T.E., Lapps W., Brian D.A. Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site. Virology. 1990;176:296–301. doi: 10.1016/0042-6822(90)90257-R. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bagai S., Lamb R.A. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J. Cell Biol. 1996;135:73–84. doi: 10.1083/jcb.135.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Berlioz-Torrent C., Shacklett B.L., Erdtmann L., Delamarre L., Bocuhaert I., Sonigo P., Dokhelar M.C., Benarous R. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. J. Virol. 1999;73:1350–1361. doi: 10.1128/jvi.73.2.1350-1361.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Binns M.M., Boursnell M.E.G., Cavanagh D., Pappin D.J.C., Brown T.D.K. Cloning and sequencing of the gene encoding the spike protein of the coronavirus IBV. J. Gen. Virol. 1985;66:719–726. doi: 10.1099/0022-1317-66-4-719. [DOI] [PubMed] [Google Scholar]
  • 5.Bos E.C., Luytjes W., Spaan W.J.M. The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: Cleavage is not required for infectivity. J. Virol. 1997;71:9427–9433. doi: 10.1128/jvi.71.12.9427-9433.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bos E.C.W., Heijnen L., Luytjes W., Spaan W.J.M. Mutational analysis of the murine coronavirus spike protein: Effect on cell-to-cell fusion. Virology. 1995;214:453–463. doi: 10.1006/viro.1995.0056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brody B.A., Rhee S.S., Hunter E. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 1994;68:4620–4627. doi: 10.1128/jvi.68.7.4620-4627.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chen B., Przybyla A.E. An efficient site-directed mutagenesis method based on PCR. BioTechniques. 1994;17:657–659. [PubMed] [Google Scholar]
  • 9.Cleverley D.Z., Lenard J. The transmembrane domain in viral fusion: Essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. USA. 1998;95:3425–3430. doi: 10.1073/pnas.95.7.3425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Delmas B., Gelfi J.R.L.H., Vogel L.K., Sjostrom H., Noren O., Laude H. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature. 1992;357:417–420. doi: 10.1038/357417a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dubay J.W., Roberts S.J., Hahn B.H., Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 1992;66:6616–6625. doi: 10.1128/jvi.66.11.6616-6625.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Eisenberg D. Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 1984;53:595–623. doi: 10.1146/annurev.bi.53.070184.003115. [DOI] [PubMed] [Google Scholar]
  • 13.Fleming J.O., Wang F.-I., Trousdale M.D., Hinton D.R., Stohlman S.A. Interaction of immune and central nervous systems: Contributions of anti-viral Thy-1+ cells to demyelination induced by coronavirus JHM. Reg. Immunol. 1993;5:37–43. [PubMed] [Google Scholar]
  • 14.Frana M.F., Behnke J.N., Sturman L.S., Holmes K.V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Host-dependent differences in proteolytic cleavage and cell fusion. J. Virol. 1985;56:912–920. doi: 10.1128/jvi.56.3.912-920.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fuerst T.R., Earl P.L., Moss B. Use of a hybrid vaccinia virus–T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 1987;7:2538–2544. doi: 10.1128/mcb.7.7.2538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Fuerst T.R., Niles E.G., Studier F.W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 1986;83:8122–8126. doi: 10.1073/pnas.83.21.8122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gallagher T.M. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. J. Virol. 1996;70:4683–4690. doi: 10.1128/jvi.70.7.4683-4690.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gallagher T.M., Escarmis C., Buchmeier M.J. Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J. Virol. 1991;65:1916–1928. doi: 10.1128/jvi.65.4.1916-1928.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gilmore W., Correale J., Weiner L.P. Coronavirus induction of class I major histocompatibility complex expression in murine astrocytes is virus strain specific. J. Exp. Med. 1994;180:1013–1023. doi: 10.1084/jem.180.3.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Glick B.S., Rothman J.E. Possible role for fatty acyl-coenzyme A in intracellular protein transport. Nature. 1987;326:309–312. doi: 10.1038/326309a0. [DOI] [PubMed] [Google Scholar]
  • 21.Glickman R.L., Syddall R.J., Iorio R.M., Sheehan J.P., Bratt M.A. Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J. Virol. 1988;62:354–356. doi: 10.1128/jvi.62.1.354-356.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gombold J.L., Hingley S.T., Weiss S.R. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 1993;67:4504–4512. doi: 10.1128/jvi.67.8.4504-4512.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gombold J.L., Sutherland R., Lavi E., Pateron Y., Weiss S.R. Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microb. Path. 1995;18:211–221. doi: 10.1016/S0882-4010(95)90058-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gombold J.L., Weiss S.R. Mouse hepatitis virus A59 increases steady-state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microb. Path. 1992;13:493–505. doi: 10.1016/0882-4010(92)90015-G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hernandez L.D., Hoffman L.R., Wolfsberg T.G., White J.M. Virus–cell and cell–cell fusion. Annu. Rev. Cell Dev. Biol. 1996;12:627–661. doi: 10.1146/annurev.cellbio.12.1.627. [DOI] [PubMed] [Google Scholar]
  • 26.Hingley S.T., Gombold J.L., Lavi E., Weiss S.R. MHV–A59 fusion mutants are attenuated and display altered hepatotropism. Virolgy. 1994;200:1–10. doi: 10.1006/viro.1994.1156. [DOI] [PubMed] [Google Scholar]
  • 27.Houtman J., Fleming J.O. Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J. Neurovirol. 1996;2:101–110. doi: 10.3109/13550289609146543. [DOI] [PubMed] [Google Scholar]
  • 28.Januszeski M.M., Cannon P.M., Chen D., Rozenberg Y., Anderson W.F. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 1997;71:3613–3619. doi: 10.1128/jvi.71.5.3613-3619.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Jin H., Subbarao K., Bagai S., Leser G.P., Murphy B.R., Lamb R. Palmitoylation of influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. J. Virol. 1996;70:1406–1414. doi: 10.1128/jvi.70.3.1406-1414.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kawaoka Y., Webster R.G. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc.Natl. Acad. Sci. USA. 1988;85:324–328. doi: 10.1073/pnas.85.2.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kemble G.W., Danieli T., White J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell. 1994;76:383–391. doi: 10.1016/0092-8674(94)90344-1. [DOI] [PubMed] [Google Scholar]
  • 32.Kunkel F., Herrler G. Structural and functional analysis of the surface protein of human coronavirus OC43. Virology. 1993;195:195–202. doi: 10.1006/viro.1993.1360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lamb R.A. Paramyxovirus fusion: A hypothesis for changes. Virology. 1993;197:1–11. doi: 10.1006/viro.1993.1561. [DOI] [PubMed] [Google Scholar]
  • 34.Lavi E., Gilden D.H., Wroblewska Z., Rorke L.B., Weiss S.R. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 1984;34:597–603. doi: 10.1212/wnl.34.5.597. [DOI] [PubMed] [Google Scholar]
  • 35.Lavi E., Highkin M.K., Fishman P.S., Weiss S.R. Limbic encephalitis after inhalation of a murine coronavirus. Lab. Invest. 1988;58:31–36. [PubMed] [Google Scholar]
  • 36.Lee H.J., Shieh C.K., Gorbalenya A.E., Koonin E.V., La Monica N., Tuler J., Bagdzhadzhyan A., Lai M.M. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology. 1991;180:567–582. doi: 10.1016/0042-6822(91)90071-I. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Li S., Wilkinson M.F. Site-directed mutagenesis: A two-step method using PCR and DpnI. BioTechniques. 1997;23:588–590. doi: 10.2144/97234bm05. [DOI] [PubMed] [Google Scholar]
  • 38.Luytjes W., Sturman L.S., Bredenbeek P.J., Charite J., van der Zeijst B.A.M., Horzinek M.C., Spaan W.J.M. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology. 1987;161:479–487. doi: 10.1016/0042-6822(87)90142-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Melikyan G.B., Brener S.A., Ok D.C., Cohen F.S. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J. Cell Biol. 1997;136:995–1005. doi: 10.1083/jcb.136.5.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Melikyan G.B., Jin H., Lamb R.A., Cohen F.S. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores. Virology. 1997;215:118–128. doi: 10.1006/viro.1997.8686. [DOI] [PubMed] [Google Scholar]
  • 41.Melikyan G.B., White J.M., Cohen F.S. GPI-anchored influenza hemagglutinin-induced hemifusion to both red blood cells and planar bilayer membranes. J. Cell Biol. 1995;131:679–691. doi: 10.1083/jcb.131.3.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Mounir S., Talbot P.J. Molecular characterization of the S protein gene of human coronavirus OC43. J. Gen. Virol. 1993;74:1981–1987. doi: 10.1099/0022-1317-74-9-1981. [DOI] [PubMed] [Google Scholar]
  • 43.Naim H.Y., Amarneh B., Ktistakis N.T., Roth M.G. Effects of altering palmitylation sites on biosynthesis and function of the influenza virus hemagglutinin. J. Virol. 1992;66:7585–7588. doi: 10.1128/jvi.66.12.7585-7588.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Nash T.C., Buchmeier M.J. Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways. Virology. 1997;23:1–8. doi: 10.1006/viro.1997.8609. [DOI] [PubMed] [Google Scholar]
  • 45.Niemann H., Klenk H.-D. Coronavirus glycoprotein E1, a new type of viral glycoprotein. J. Mol. Biol. 1981;153:993–1010. doi: 10.1016/0022-2836(81)90463-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Nussbaum O., Broder C.C., Berger E.A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 1994;68:5411–5422. doi: 10.1128/jvi.68.9.5411-5422.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Odell D., Wanas E., Yan J., Ghosh H.P. Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein. J. Gen. Virol. 1997;71:7996–8000. doi: 10.1128/jvi.71.10.7996-8000.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Pachuk C.J., Bredenbeek P.J., Zoltick P.W., Spaan W.J.M., Weiss S.R. Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis virus strain A59. Virology. 1989;171:141–148. doi: 10.1016/0042-6822(89)90520-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Parker S.E., Gallagher T.M., Buchmeier M.J. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology. 1989;173:664–673. doi: 10.1016/0042-6822(89)90579-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Perez L.G., Hunter E. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to pg85 and gp37. J. Virol. 1987;61:1609–1614. doi: 10.1128/jvi.61.5.1609-1614.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Ponimaskin E., Schmidt M.F.G. Acylation of viral glycoproteins: Structural requirements for palmitoylation of transmembrane proteins. Biochem. Soc. Trans. 1995;23:565–568. doi: 10.1042/bst0230565. [DOI] [PubMed] [Google Scholar]
  • 52.Raabe T., Schelle-Prinz B., Siddell S.G. Nucleotide sequence for the gene encoding the spike glycoprotein of human coronavirus HCV 229E. J. Gen. Virol. 1990;71:1065–1073. doi: 10.1099/0022-1317-71-5-1065. [DOI] [PubMed] [Google Scholar]
  • 53.Ragheb J.A., Anderson F.W. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: Implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 1994;68:3220–3231. doi: 10.1128/jvi.68.5.3220-3231.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ragheb J.A., Anderson W.F. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: A functional analysis of the role of TM domains in viral entry. J. Virol. 1994;68:3207–3219. doi: 10.1128/jvi.68.5.3207-3219.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Rasschaert D., Laude H. The predicted structure of the peplomer protein E2 of the porcine coronavirus transmissible gastroenteritis virus. J. Gen. Virol. 1987;68:1883–1890. doi: 10.1099/0022-1317-68-7-1883. [DOI] [PubMed] [Google Scholar]
  • 56.Rein A., Mirro J., Haynes J.G., Ernst S.M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E–p2E cleavage activates the membrane fusion capability of the murine leukemia virus env protein. J. Virol. 1994;68:1773–1781. doi: 10.1128/jvi.68.3.1773-1781.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ritter G.D., Mulligan M.J., Lydy S.L., Compans R.W. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology. 1993;197:255–264. doi: 10.1006/viro.1993.1586. [DOI] [PubMed] [Google Scholar]
  • 58.Rose J.K., Adams G.A., Gallione C.J. The presence of cysteine in the cytoplasmic domain of the vesicular stomatitis virus glycoprotein is required for palmitate addition. Proc. Natl. Acad. Sci. USA. 1984;81:2050–2054. doi: 10.1073/pnas.81.7.2050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Salzwedel K., Johnston P.B., Roberts S.J., Dubay J.W., Hunter E. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 1993;67:5279–5288. doi: 10.1128/jvi.67.9.5279-5288.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Schlesinger M.J., Veit M., Schmidt M.F.G. Palmitoylation of cellular and viral proteins. In: Schlesinger M.J., editor. Lipid Modifications of Proteins. CRC Press; Boca Raton: 1993. pp. 1–19. [Google Scholar]
  • 61.Schmidt M.F.G. Acylation of viral spike glycoproteins: A feature of enveloped RNA viruses. Virology. 1982;116:327–338. doi: 10.1016/0042-6822(82)90424-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Schmidt M.F.G. Fatty acylation of proteins. Biochim. Biophys. Acta. 1989;988:411–426. doi: 10.1016/0304-4157(89)90013-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Schroth-Diez B., Ponimaskin E., Reverey H., Schmidt M.F.G., Herrmann A. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin. J. Virol. 1998;72:133–141. doi: 10.1128/jvi.72.1.133-141.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Sefton B.M., Buss J.E. The covalent modification of eukaryotic proteins with lipid. J. Cell Biol. 1987;104:1449–1453. doi: 10.1083/jcb.104.6.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Stauber R., Pfleiderera M., Siddell S.G. Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for fusion activity. J. Gen. Virol. 1993;74:183–191. doi: 10.1099/0022-1317-74-2-183. [DOI] [PubMed] [Google Scholar]
  • 66.Sturman L.S., Holmes K.V., Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 1980;33:449–462. doi: 10.1128/jvi.33.1.449-462.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Sturman L.S., Ricard C.S., Holmes K.V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 1985;56:904–911. doi: 10.1128/jvi.56.3.904-911.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Taguchi F., Ikeda T., Shida H. Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J. Gen. Virol. 1992;73:1065–1072. doi: 10.1099/0022-1317-73-5-1065. [DOI] [PubMed] [Google Scholar]
  • 69.van Berlo M.F., van den Brink W.J., Horzinek M.C., van der Zeijst B.A.M. Fatty acid acylation of viral proteins in murine hepatitis virus-induced cells. Arch. Virol. 1987;95:123–128. doi: 10.1007/BF01311339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Vennema H., Heijnen L., Zijderveld A., Horzinek M.C., Spaan W.J.M. Intracellular transport of recombinant coronavirus spike proteins: Implications for virus assembly. J. Virol. 1990;64:339–346. doi: 10.1128/jvi.64.1.339-346.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Wang F.-I., Stohlman S.A., Fleming J.O. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol. 1990;30:31–41. doi: 10.1016/0165-5728(90)90050-W. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Watanabe R., Wege H., ter Meulen V. Adoptive transfer of EAE-like lesions by BMP-stimulated lymphocytes from rats with coronavirus-induced demyelinating encephalomyelitis. Nature. 1983;305:150–153. doi: 10.1038/305150a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Weiner L.P. Pathogenesis of demyelination induced by mouse hepatitis virus (JHM) Arch. Neurol. 1973;28:298–303. doi: 10.1001/archneur.1973.00490230034003. [DOI] [PubMed] [Google Scholar]
  • 74.White J.M. Membrane fusion. Science. 1992;258:917–924. doi: 10.1126/science.1439803. [DOI] [PubMed] [Google Scholar]
  • 75.Wilk T., Pfeiffer T., Bosch V. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology. 1992;189:167–177. doi: 10.1016/0042-6822(92)90692-i. [DOI] [PubMed] [Google Scholar]
  • 76.Yang, C., and Compans, R. W. (196). Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: Inhibitory effects of the R peptide. J. Virol.70, 248–254. [DOI] [PMC free article] [PubMed]
  • 77.Yang C., Compans R.W. Analysis of the murine leukemia virus R peptide: Delineation of the molecular determinants which are important for its fusion inhibition activity. J. Virol. 1997;71:8490–8496. doi: 10.1128/jvi.71.11.8490-8496.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Yao Q., Compans R.W. Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins. J. Virol. 1995;69:7045–7053. doi: 10.1128/jvi.69.11.7045-7053.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Zurcher T., Luo G.X., Palese P. Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation. J. Virol. 1994;68:5748–5754. doi: 10.1128/jvi.68.9.5748-5754.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virology are provided here courtesy of Elsevier

RESOURCES